Search Login Register
beraprost
Summary
142
relevant articles (25 outcomes,
28 trials/studies)
found for this Bio-Agent
Description:
stable prostacyclin analog; structure given in first source
Also Known As:
4-(1,2,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyloct-6-yne-1-enyl)-5-cyclopenta(b)benzofuranyl)butyrate; TRK 100; TRK-100; beraprost sodium; 1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-, monosodium salt
Key Diseases for which beraprost is
Relevant
-
Pulmonary Hypertension (Ayerza Syndrome)
:
6 outcomes 3 studies in 39 results
-
Hypertension (High Blood Pressure)
:
5 outcomes 4 studies in 16 results
-
Systemic Scleroderma (Systemic Sclerosis)
:
3 outcomes 1 study in 4 results
-
Peripheral Vascular Diseases (Peripheral Vascular Disease)
:
2 outcomes 2 studies in 4 results
-
Thromboangiitis Obliterans (Buerger's Disease)
:
2 outcomes 1 study in 2 results
Show All >>
Drugs Related to beraprost
-
Epoprostenol (Prostacyclin)
-
sildenafil (Viagra)
-
beraprost
-
bosentan (Tracleer)
-
Vasodilator Agents (Vasodilators)
-
Alprostadil (Muse)
-
Iloprost (Ventavis)
-
Endothelin Receptors (Endothelin Receptor)
-
Prostaglandins I
-
Dinoprostone (PGE2)
Show All >>
Therapies Related to beraprost
-
Ligation
-
Prostheses and Implants (Prosthesis)
-
Lung Transplantation
-
Isogeneic Transplantation
-
Transplants (Transplant)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.